M
Melisa Litchfield
Researcher at University of New South Wales
Publications - 20
Citations - 928
Melisa Litchfield is an academic researcher from University of New South Wales. The author has contributed to research in topics: Population & Cohort study. The author has an hindex of 9, co-authored 19 publications receiving 681 citations. Previous affiliations of Melisa Litchfield include University of Sydney.
Papers
More filters
Journal ArticleDOI
The Australian Pharmaceutical Benefits Scheme data collection: a practical guide for researchers
Leigh Mellish,Emily A Karanges,Melisa Litchfield,Andrea L Schaffer,Bianca Blanch,Benjamin Daniels,Alicia Segrave,Sallie-Anne Pearson,Sallie-Anne Pearson +8 more
TL;DR: This paper provides a practical guide to researchers using PBS data to examine prescribed medicine use and describes the core components of four publicly available extracts.
Journal ArticleDOI
International trends in antipsychotic use: A study in 16 countries, 2005-2014
Oskar Halfdanarson,Helga Zoega,Lise Aagaard,Miquel Bernardo,Lena Brandt,Anna Coma Fusté,Kari Furu,Kristina Garuoliene,Falk Hoffmann,Krista F. Huybrechts,Luuk J. Kalverdijk,Koji Kawakami,Helle Kieler,Takuya Kinoshita,Melisa Litchfield,Soffy C. López,Jorge Enrique Machado-Alba,Manuel Enrique Machado-Duque,Mufaddal Mahesri,Prasad S. Nishtala,Sallie-Anne Pearson,Johan Reutfors,Leena K. Saastamoinen,Izumi Sato,Catharina C. M. Schuiling-Veninga,Yu-Chiau Shyu,Svetlana Skurtveit,Hélène Verdoux,Liang-Jen Wang,Corinne Zara Yahni,Christian Bachmann +30 more
TL;DR: In the majority of populations, antipsychotic utilisation and especially the use of atypical antipsychotics increased over time, and quetiapine, risperidone, and olanzapine were most frequently prescribed.
Journal ArticleDOI
Cohort Profile: The Concord Health and Ageing in Men Project (CHAMP)
Robert G. Cumming,David J. Handelsman,Markus J. Seibel,Helen Creasey,Philip N. Sambrook,Louise M. Waite,Vasi Naganathan,David G. Le Couteur,Melisa Litchfield +8 more
TL;DR: The Concord Health and Ageing in Men Project (CHAMP) was established to investigate health in old men, defined as age 70 years and over, and there is no upper age limit for recruitment into CHAMP.
Journal ArticleDOI
Ambient UV, personal sun exposure and risk of multiple primary melanomas
Anne Kricker,Bruce K. Armstrong,Chris Goumas,Melisa Litchfield,Colin B. Begg,Amanda J. Hummer,Loraine D. Marrett,Beth Theis,Robert C. Millikan,Nancy E. Thomas,Hoda Anton Culver,Richard P. Gallagher,Terence Dwyer,Timothy R. Rebbeck,Peter A. Kanetsky,Klaus J. Busam,Lynn From,Urvi Mujumdar,Roberto Zanetti,Marianne Berwick +19 more
TL;DR: Recreational exposure at any age increased risk and appeared to add to risk from ambient UV in early life and people who have had a melanoma can expect to reduce their risk of a further melanoma by reducing recreational sun exposure whatever their age.
Journal ArticleDOI
Polypharmacy among older Australians, 2006-2017: a population-based study.
Amy Page,Amy Page,Michael O. Falster,Melisa Litchfield,Sallie-Anne Pearson,Sallie-Anne Pearson,Christopher Etherton-Beer,Christopher Etherton-Beer +7 more
TL;DR: To estimate the prevalence of polypharmacy among Australians aged 70 years or more, 2006–2017, the National Library of Australia commissioned a meta-analysis of official records to establish a baseline for this study.